A detailed history of ETF Managers Group, LLC transactions in Chimerix Inc stock. As of the latest transaction made, ETF Managers Group, LLC holds 29,405 shares of CMRX stock, worth $25,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,405
Previous 21,951 33.96%
Holding current value
$25,876
Previous $40,000 7.5%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$1.19 - $2.09 $8,870 - $15,578
7,454 Added 33.96%
29,405 $37,000
Q4 2022

Mar 23, 2023

SELL
$1.67 - $2.35 $6,523 - $9,179
-3,906 Reduced 15.11%
21,951 $40,000
Q3 2022

Nov 14, 2022

SELL
$1.81 - $2.76 $3,198 - $4,876
-1,767 Reduced 6.4%
25,857 $50,000
Q2 2022

Aug 15, 2022

BUY
$1.34 - $5.34 $1,642 - $6,546
1,226 Added 4.64%
27,624 $57,000
Q1 2022

May 13, 2022

BUY
$4.58 - $6.8 $650 - $965
142 Added 0.54%
26,398 $122,000
Q4 2021

Feb 14, 2022

SELL
$5.23 - $7.18 $22,970 - $31,534
-4,392 Reduced 14.33%
26,256 $174,000
Q3 2021

Nov 15, 2021

BUY
$5.94 - $8.75 $31,006 - $45,675
5,220 Added 20.53%
30,648 $190,000
Q2 2021

Aug 16, 2021

SELL
$7.54 - $9.79 $6,499 - $8,438
-862 Reduced 3.28%
25,428 $192,000
Q1 2021

May 17, 2021

SELL
$4.76 - $11.25 $19,873 - $46,968
-4,175 Reduced 13.7%
26,290 $226,000
Q4 2020

Feb 16, 2021

SELL
$2.43 - $5.42 $10,614 - $23,674
-4,368 Reduced 12.54%
30,465 $148,000
Q3 2020

Nov 16, 2020

BUY
$2.3 - $3.72 $38,370 - $62,060
16,683 Added 91.92%
34,833 $88,000
Q2 2020

Aug 14, 2020

BUY
$1.33 - $3.63 $24,139 - $65,884
18,150 New
18,150 $57,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $77.1M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.